These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37349201)

  • 21. Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unknown origin patients.
    Chen Z; Li Y; Wang Q; Weng S; Zhou Y; Zhu J
    Clin Rheumatol; 2022 Mar; 41(3):839-846. PubMed ID: 34674082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
    St-Pierre F; Broski SM; LaPlant BR; Maurer MJ; Ristow K; Thanarajasingam G; Macon WR; Habermann TM; Witzig TE
    Oncologist; 2020 Aug; 25(8):689-695. PubMed ID: 32319706
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Munhoz L; de Brito MAD; Arita ES; Sapienza MT
    Oral Radiol; 2021 Oct; 37(4):669-676. PubMed ID: 33428105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positron emission tomography/computed tomography (PET/CT) in multiple myeloma].
    Sachpekidis C; Goldschmidt H; Dimitrakopoulou-Strauss A
    Radiologe; 2022 Jan; 62(1):20-29. PubMed ID: 34921323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Interobserver Agreement and Diagnostic Accuracy for IASLC/ITMIG Thymic Epithelial Tumor Staging Among Co-registered FDG-PET/MRI, Whole-body MRI, Integrated FDG-PET/CT, and Conventional Imaging Examination with and without Contrast Media Administrations.
    Ohno Y; Kishida Y; Seki S; Koyama H; Yui M; Aoyagi K; Yoshikawa T
    Acad Radiol; 2022 Mar; 29 Suppl 3():S122-S131. PubMed ID: 29395795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
    Juweid ME; Mueller M; Alhouri A; A-Risheq MZ; Mottaghy FM
    Cancer; 2021 Oct; 127(20):3727-3741. PubMed ID: 34286864
    [No Abstract]   [Full Text] [Related]  

  • 27. Mediastinal Masses:
    Mikail N; Khalil A; Rouzet F
    Semin Nucl Med; 2021 Jan; 51(1):79-97. PubMed ID: 33246542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
    Tanaka H; Yoshida S; Komai Y; Sakai Y; Urakami S; Yuasa T; Yamamoto S; Masuda H; Koizumi M; Kohno A; Fukui I; Yonese J; Fujii Y; Kihara K
    Urol Int; 2016; 96(1):65-72. PubMed ID: 26044598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of positron emission tomography imaging in the diagnosis of chronic Q fever: A Systematic Review.
    Sivabalan P; Visvalingam R; Grey V; Blazak J; Henderson A; Norton R
    J Med Imaging Radiat Oncol; 2021 Oct; 65(6):694-709. PubMed ID: 34056851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Sekine T; Barbosa FG; Delso G; Burger IA; Stolzmann P; Ter Voert EE; Huber GF; Kollias SS; von Schulthess GK; Veit-Haibach P; Huellner MW
    Head Neck; 2017 Aug; 39(8):1550-1558. PubMed ID: 28500749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptual omission errors in positron emission tomography and computed tomography reporting.
    Godefroy J; Ben Haim S; Rosenbach E; Meital AN; Levy A; Chicheportiche A; Bar-Shalom R
    Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):75-82. PubMed ID: 33686849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
    Seol HY; Kim YS; Kim SJ
    Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
    Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaysian consensus statement on FDG PET-CT reporting format for lymphoma.
    Tan TH; Wong TH; Khoo CH; Mahaletchumy T; Ng CS; Ghazali MW
    Med J Malaysia; 2021 Sep; 76(5):685-690. PubMed ID: 34508375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actionable imaging findings in the daily PET/CT scenario.
    Mattana F; Zanoni L; Nanni C; Mosconi C; Brocchi S; Golfieri R; Fanti S
    Clin Transl Imaging; 2023; 11(2):127-139. PubMed ID: 36846503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
    Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
    Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
    Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET/CT for oral focus assessment in head and neck cancer patients.
    Schwaninger DR; Hüllner M; Bichsel D; Giacomelli-Hiestand B; Stutzmann NS; Balermpas P; Valdec S; Stadlinger B
    Clin Oral Investig; 2022 Jun; 26(6):4407-4418. PubMed ID: 35254526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.